ARTBIO Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) (NCT07214961) | ARTBIO Inc. | 2025-11-03 |
| Phase 0/1 Study of 212Pb-NG001 in mCRPC (NCT05725070) | ARTBIO Inc. | 2023-03-06 |
Track ARTBIO Inc. automatically
Every clearance here is in the API, with alerts when new ones post.